Results 201 to 210 of about 83,985 (257)
Editorial: Evaluating differentiation therapy and biomarkers in myeloid malignancies. [PDF]
Noguera NI, Hasan SK, Cicconi L.
europepmc +1 more source
[Hematological changes in children with neoplasms].
M, Ochocka +2 more
openaire +1 more source
When Blasts Speak Louder Than Flow: A Diagnostic Challenge in Suspected Hematologic Malignancy. [PDF]
Izadian Bidgoli A +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Rheumatologic Manifestations of Hematologic Neoplasms
Current Rheumatology Reviews, 2017The rheumatologic manifestations of hematologic neoplasms are a collection of diverse syndromes. This review aims to describe the most common syndromes in the context of potential mechanisms of pathogenesis.We undertook a structured search of the available peer-reviewed literature describing paraneoplastic phenomena associated with hematologic ...
A, Wang, C M, Brunet, A M, Zeidan
exaly +3 more sources
Flow cytometric immunophenotyping for hematologic neoplasms
Blood, 2008AbstractFlow cytometric immunophenotyping remains an indispensable tool for the diagnosis, classification, staging, and monitoring of hematologic neoplasms. The last 10 years have seen advances in flow cytometry instrumentation and availability of an expanded range of antibodies and fluorochromes that have improved our ability to identify different ...
Fiona Craig +2 more
exaly +3 more sources
Neurologic complications of hematologic neoplasms
Neurologic Clinics, 2003The new WHO classification of hematopoietic and lymphatic neoplasms was devised to offer pathologists, oncologists, and geneticists a system of classification based on histopathologic, clinical, and genetic features. From the neurologic standpoint, it offers an opportunity to consolidate the complications produced by leukemias, lymphomas, and plasma ...
Lawrence, Recht, Maciej, Mrugala
openaire +2 more sources
Immunologic Aspects of the Hematologic Neoplasms
Postgraduate Medicine, 1973Understanding the pathogenesis and pathophysiology of the hematologic malignancies now requires knowledge of their immunology. Many of these tumors appear to arise from the immune cells themselves (B or T cell tumors); most have associated disturbances in immune cell function.
S E, Jones, B G, Durie, S E, Salmon
openaire +2 more sources

